-transparent.png){kind=logo}
Alpha interferon (IFN-alpha) represents the best therapy for HCV active chronic hepatitis, but only 25% of treated patients achieve a complete recovery. Several attempts have been made to increase this percentage. The objective of our study is to verify whether the combination ribavirin (R)+ IFN-alpha can lead to positive results in non-responders to treatment with IFN-alpha alone. The preliminary results for 5 subjects, all non-responders to IFN, treated with R+ IFN for 60 days and then IFN alone for 4 months more show that during the R+IFN treatment, 2 subjects presented a reduction in transaminase; a month after the suspension of R, ALT returned to pre-treatment values. The results are preliminary but we can say that this combination in the proposed doses and times in these subjects, cannot be considered adequate to modify the natural course of this disease.
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
January 2000,
Journal of viral hepatitis,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
February 2000,
Zeitschrift fur Gastroenterologie,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
January 2000,
Digestion,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
August 1998,
Alimentary pharmacology & therapeutics,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
January 1999,
Scandinavian journal of infectious diseases,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
January 2000,
Hepato-gastroenterology,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
November 1999,
Italian journal of gastroenterology and hepatology,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
April 2000,
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
November 2004,
JPMA. The Journal of the Pakistan Medical Association,
G Scotto, and
S Ferrara, and
A Mangano, and
P E Conte, and
G Tantimonaco
April 1999,
Gastroenterologie clinique et biologique,
